We are live on
!
Find out more
PL
Pluribus Labs Portfolio holdings
AUM
$54.8M
This Fund
S&P 500
This Quarter
Est. Return
-2.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$25.2M
AUM Growth
-$69.7M
(-73%)
Cap. Flow
-$68.8M
Cap. Flow
% of AUM
-273.42%
Top 10 Holdings %
Top 10 Hldgs %
58.31%
Holding
244
New
16
Increased
13
Reduced
15
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$505K |
| 2 |
Blackrock
BLK
|
+$373K |
| 3 |
Prologis
PLD
|
+$358K |
| 4 |
IBM
IBM
|
+$321K |
| 5 |
Lockheed Martin
LMT
|
+$310K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRSH
Marsh
MRSH
|
+$1.04M |
| 2 |
Public Service Enterprise Group
PEG
|
+$879K |
| 3 |
Verizon
VZ
|
+$872K |
| 4 |
QVCGA
QVC Group Inc Series A
QVCGA
|
+$813K |
| 5 |
MasTec
MTZ
|
+$788K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Consumer Discretionary | 15.05% |
| 3 | Healthcare | 13.51% |
| 4 | Communication Services | 13.02% |
| 5 | Financials | 12.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
BOK Financial
BOKF
$8.58B
| – | – |
-2,647
| Closed | -$279K |
|
77
Broadridge
BR
$17.3B
| – | – |
-2,086
| Closed | -$381K |
|
78
Bruker
BRKR
$8.86B
| – | – |
-4,667
| Closed | -$392K |
|
79
Brown & Brown
BRO
$23.5B
| – | – |
-3,406
| Closed | -$239K |
|
80
Citigroup
C
$217B
| – | – |
-3,751
| Closed | -$227K |
|
81
Caterpillar
CAT
$405B
| – | – |
-2,254
| Closed | -$466K |
|
82
Crown Castle
CCI
$34.6B
| – | – |
-1,682
| Closed | -$351K |
|
83
Century Communities
CCS
$1.89B
| – | – |
-3,674
| Closed | -$300K |
|
84
Century Aluminum
CENX
$4.11B
| – | – |
-21,856
| Closed | -$362K |
|
85
Church & Dwight Co
CHD
$23.2B
| – | – |
-1,968
| Closed | -$202K |
|
86
Clean Energy Fuels
CLNE
$524M
| – | – |
-67,222
| Closed | -$412K |
|
87
Cummins
CMI
$89.5B
| – | – |
-1,438
| Closed | -$314K |
|
88
CMS Energy
CMS
$22.8B
| – | – |
-4,131
| Closed | -$269K |
|
89
CONMED
CNMD
$1.3B
| – | – |
-1,856
| Closed | -$263K |
|
90
PC Connection
CNXN
$1.99B
| – | – |
-5,566
| Closed | -$240K |
|
91
Cencora
COR
$59.9B
| – | – |
-5,134
| Closed | -$682K |
|
92
Coty
COTY
$2.3B
| – | – |
-30,049
| Closed | -$316K |
|
93
Comstock Resources
CRK
$3.92B
| – | – |
-15,178
| Closed | -$123K |
|
94
Charles River Laboratories
CRL
$10.8B
| – | – |
-1,376
| Closed | -$518K |
|
95
Salesforce
CRM
$140B
| – | – |
-846
| Closed | -$215K |
|
96
Cerence
CRNC
$390M
| – | – |
-5,031
| Closed | -$386K |
|
97
Carpenter Technology
CRS
$27.7B
| – | – |
-14,294
| Closed | -$417K |
|
98
CoStar Group
CSGP
$12.2B
| – | – |
-3,594
| Closed | -$284K |
|
99
Corteva
CTVA
$58.4B
| – | – |
-6,431
| Closed | -$304K |
|
100
Camping World
CWH
$393M
| – | – |
-6,867
| Closed | -$277K |
|
Similar funds
BAM
KIP
CRCM
FA
LCM
IRF
ACI
NPGCU
Pluribus Labs's Q1 2022 Portfolio in Review
As of Q1 2022, Pluribus Labs held 244 positions worth $25.2M, down 73% from $94.8M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
Pluribus Labs withdrew a net $68.8M in Q1 2022, closing 200 positions and reducing 15 holdings. Its most notable exit was Marsh, an estimated $1.04M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Pluribus Labs opened a new position in Merck worth $526K.
- Pluribus Labs's largest Q1 2022 buy was Merck: 6,405 shares worth $526K.
- Pluribus Labs added most to Apple in Q1 2022, an estimated $289K increase.
- Pluribus Labs's biggest Q1 2022 reduction was Johnson & Johnson, cutting an estimated $647K.
- Pluribus Labs fully exited Marsh in Q1 2022, selling an estimated $1.04M.
- Pluribus Labs's ten largest holdings make up 58% of its $25.2M portfolio in Q1 2022.
- Pluribus Labs opened 16 new positions and closed 200 in Q1 2022.
- Pluribus Labs's portfolio value fell 73% quarter-over-quarter to $25.2M.
Based on Pluribus Labs's 13F filing for Q1 2022, filed 16 May 2022.